Search
Selected: All

Dosages for treatment with anti-ErbB2 antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Dosages for treatment with anti-ErbB2 antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Enhanced intercellular interaction by associational antibody mol

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Fixed dosing of HER antibodies

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Human DR4 antibodies and uses thereof

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Human Mob-5 (IL-24) receptors and uses thereof

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibition of small cell lung cancer cell growth in vivo using m

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Inhibition of tumor growth by blockade of the protein C system

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Junctional adhesion molecule-C (JAM-C) binding compounds and...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of inhibiting tumor growth using antibodies to MN protein

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods for diagnosis and treatment of PH domain signal...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods for improved targeting of antibody, antibody...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reissue Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of cancer diagnosis and therapy targeted against a...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of cancer diagnosis and therapy targeted against a...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of treating cancerous cells with anti-receptor antibodie

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Methods of using antibodies to human receptor protein 4-1BB

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

MN-specific antibodies and their use in cancer treatment

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Monoclonal antibodies directed to the HER2 receptor

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Monoclonal antibodies directed to the HER2 receptor

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Monoclonal antibodies having property of causing apoptosis

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.